# Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects

> **NCT02341638** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 148 (actual)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** BMS-986141
- **DRUG:** Placebo
- **DRUG:** Aspirin
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT02341638
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2017-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02341638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02341638, "Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02341638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*